Clinical Trial Update: Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating whether a GnRH agonist given after hCG in the initial follicular phase influences prognosis of in vitro fertilization…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Gonadotropin-releasing hormone agonist
• Human chorionic gonadotropin (human chorionic gonadotropin)

Snippet

Sponsor: University of Sao Paulo | Conditions: Infertility | Phase 3 | Status: UNKNOWN